-
Mashup Score: 0
Risk stratification is useful in predicting outcomes and guiding treatment of patients with PAH, aiming to reach a low mortality risk; in addition to validated risk tools, PVR-associated markers are increasingly relevant in guiding treatment decisions. https://bit.ly/4cHFY6H
Source: erj.ersjournals.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
Risk stratification is useful in predicting outcomes and guiding treatment of patients with PAH, aiming to reach a low mortality risk; in addition to validated risk tools, PVR-associated markers are increasingly relevant in guiding treatment decisions. https://bit.ly/4cHFY6H
Source: erj.ersjournals.comCategories: General Medicine News, CardiologistsTweet-
Risk stratification and treatment goals in pulmonary arterial hypertension. The Seventh World Symposium on Pulmonary Hypertension #PAH https://t.co/PiD1fz0C6A https://t.co/Tj5Ijm8vCC
-
-
Mashup Score: 0
Risk stratification is useful in predicting outcomes and guiding treatment of patients with PAH, aiming to reach a low mortality risk; in addition to validated risk tools, PVR-associated markers are increasingly relevant in guiding treatment decisions. https://bit.ly/4cHFY6H
Source: erj.ersjournals.comCategories: General Medicine News, CardiologistsTweet-
Risk stratification and treatment goals in pulmonary arterial hypertension. The Seventh World Symposium on Pulmonary Hypertension #PAH https://t.co/PiD1fz0C6A https://t.co/Tj5Ijm8vCC
-
-
Mashup Score: 0
Since 1960, pulmonary hypertension has been the focus of WHO committee reports and World Symposia proceedings. The conclusions from the 7th World Symposium on Pulmonary Hypertension are now published in the European Respiratory Journal. https://bit.ly/4ePMZ6H
Source: erj.ersjournals.comCategories: General Medicine News, CardiologistsTweet-
Proceedings from The Seventh World Symposium on Pulmonary Hypertension now available https://t.co/FNcPq8yM8u https://t.co/PZVhLAERDe
-
-
Mashup Score: 0Antithrombotic Therapy for VTE Disease - 4 month(s) ago
The American College of Chest Physicians (CHEST) Antithrombotic Therapy for Venous Thromboembolism Disease evidence-based guidelines are now updated in a more frequent, focused manner. Guidance statements from the most recent full guidelines and two subsequent updates have not been gathered into a single source. An international panel of experts with experience in prior antithrombotic therapy guideline development reviewed the 2012 CHEST antithrombotic therapy guidelines and its two subsequent updates.
Source: journal.chestnet.orgCategories: General Medicine News, CardiologistsTweet-
Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021. https://t.co/0CC1HFUFJT #OpenAccess https://t.co/3HjhZEhzsK
-
Risk stratification and treatment goals in pulmonary arterial hypertension. The Seventh World Symposium on Pulmonary Hypertension #PAH https://t.co/PiD1fz0C6A https://t.co/Tj5Ijm8vCC